Park, S., Kim, A., Cho, H., Baik, D., Lee, H., Cho, S., & Kang, H. (2020). Cost-utility analysis of pralatrexate for relapsed or refractory peripheral T-cell lymphoma based on a case-matched historical control study along with single arm clinical trial. BMC Cancer.

Park, Seonyoung, Ah-Young Kim, Hyeonseok Cho, Deborah Baik, Hankil Lee, Sunghwa Cho, et Hye-Young Kang. "Cost-utility Analysis of Pralatrexate for Relapsed or Refractory Peripheral T-cell Lymphoma Based On a Case-matched Historical Control Study Along With Single Arm Clinical Trial." BMC Cancer 2020.

Park, Seonyoung, et al. "Cost-utility Analysis of Pralatrexate for Relapsed or Refractory Peripheral T-cell Lymphoma Based On a Case-matched Historical Control Study Along With Single Arm Clinical Trial." BMC Cancer 2020.